What is the neurologic diseases biorepository?
The Multiple Sclerosis - Neurological Diseases Biorepository is a confidential list of people with multiple sclerosis (MS) and other neurological diseases who are willing to donate samples and provide health information for scientific research.
Scientists use this information to understand how and why MS and other neurologic diseases happen, and make progress toward better treatments and prevention. All of the information gathered is kept confidential, and samples and health information are coded with numbers, not names.
We are also looking for family members of all ages who do not have a neurologic disease other immune-mediated or autoimmune diseases, to join our Healthy Control Biorepository.
Participating in research typically involves a 45- minute to -one- hour visit to BRI in downtown Seattle. Our team will collect a blood sample and ask questions about your personal and family medical history. All samples and information are kept confidential. Learn more: Biorepository FAQ
Learn more about multiple sclerosis.
Participate in Neurologic Disease Research
We are currently enrolling individuals, age 18 and older, with a diagnosis of multiple sclerosis who are and are not receiving immune-modulating treatment.
Are you living with a neurological disease?
What Neurologic Disease Research is BRI Conducting?
- Understanding how and why MS starts
- Seeking out new targets that could lead to new ways to treat or prevent MS and other neurologic diseases
- Identifying more personalized medicines for MS and other neurologic diseases
Labs Studying Neurological Diseases
Bettelli Lab
Buckner Lab
Campbell Lab
Kwok Lab
Speake Lab
Stefani Lab
What Do T Cells Like to Eat? The Answer Could Stop Multiple Sclerosis
BRI's Vision of Immune Health
Using AI and VR to Advance Research
Caroline Stefani, PhD, became fascinated with the immune system while pursuing her doctorate in microbiology. She loved using imaging tools to examine the worlds of cells and bacteria. But one thing frustrated her.
